Skip to main content
2invest AG logo

2invest AG — Investor Relations & Filings

Ticker · 2INV ISIN · DE000A3H3L44 LEI · 391200H5BDEVHMOV3U10 F Financial and insurance activities
Filings indexed 93 across all filing types
Latest filing 2010-08-03 Annual Report
Country DE Germany
Listing F 2INV

About 2invest AG

https://2invest-ag.com/

2invest AG is an investment company that acquires, holds, manages, and sells investments in corporations and partnerships. The company primarily, but not exclusively, focuses on the biotechnology, life science, and IT sectors. Its investment scope is global, encompassing both listed and non-listed companies as well as other financial instruments. Investment decisions are based on attractive risk-reward profiles with the objective of achieving a risk-adequate, long-term total return.

Recent filings

Filing Released Lang Actions
Jahresabschluss zum Geschäftsjahr vom 01.04.2009 bis zum 31.03.2010
Annual Report Classification · 100% confidence The document is a comprehensive financial report for SYGNIS Pharma AG for the fiscal year ending March 31, 2010. It includes the 'Jahresabschluss' (Annual Financial Statements), 'Lagebericht' (Management Report), 'Bestätigungsvermerk' (Audit Opinion), 'Bilanz' (Balance Sheet), 'Gewinn- und Verlustrechnung' (Income Statement), and 'Anhang' (Notes to the Financial Statements). Since this is a full annual financial report containing audited statements and management analysis, it is classified as an Annual Report (10-K). FY 2010
2010-08-03 German
Konzernabschluss zum Geschäftsjahr vom 01.04.2009 bis zum 31.03.2010
Annual Report Classification · 100% confidence The document is a comprehensive annual report for SYGNIS Pharma AG for the fiscal year 2009/2010. It includes the 'Konzernabschluss' (Consolidated Financial Statements) prepared under IFRS, a 'Konzernlagebericht' (Management Report), detailed financial tables (revenue, expenses, earnings), and analysis of business development. It is clearly a full annual report rather than an announcement or a summary. FY 2010
2010-07-30 German
Datum:11.02.2010
Report Publication Announcement Classification · 100% confidence The document is a short notification (829 characters) announcing the availability of a quarterly financial report ('Quartalsfinanzbericht') for Sygnis Pharma AG. It provides a URL to access the report and details regarding the publication date and media distribution. Per the 'Menu vs Meal' rule, since this is a short announcement of a report rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2010-02-11 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.